InnoCan Pharma Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
11
- Stock Symbol
-
INNO
- Investments
-
2
- Share Price
-
$1.16
- (As of Friday Closing)
InnoCan Pharma General Information
Description
InnoCan Pharma Corp develops consumer wellness and pharmaceutical products. It has developed a preclinical-stage Cannabidiol-loaded Liposome injection Platform (CBD-LPT) for non-opioid pain management, and is involved in developing and marketing various self-care and CBD beauty products. Additionally, the Group offers cosmetic products such as anti-aging beauty sleeping masks, anti-puffiness eye serum, anti-aging facial serum, hair cream, etc., which are sold mainly through online marketplaces. Its operating segments are: Online sales and Other operations. The majority of its revenue is generated from the Online sales segment, which engages in the development, manufacture, and marketing of cosmetic products. Geographically, the Group generates maximum revenue from the United States.
Contact Information
Website
www.innocanpharma.comCorporate Office
- 10 Hamenofim Street
- Herzliya 4672561
- Israel
Corporate Office
- 10 Hamenofim Street
- Herzliya 4672561
- Israel
InnoCan Pharma Timeline
InnoCan Pharma Stock Performance
As of 13-Nov-2026, InnoCan Pharma’s stock price is $1.16. Its current market cap is $5.2M with 4.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.16 | $1.30 | $1.13 - $11.75 | $5.2M | 4.5M | 2.59K | -$0.26 |
InnoCan Pharma Financials Summary
As of 30-Jun-2026, InnoCan Pharma has a trailing 12-month revenue of $23.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 5,478 | 18,990 | 38,910 | 58,868 |
| Revenue | 23,525 | 26,612 | 29,437 | 13,657 |
| EBITDA | (830) | 130 | 961 | (4,024) |
| Net Income | (959) | (1,124) | (1,834) | (4,700) |
| Total Assets | 10,365 | 10,522 | 9,260 | 6,940 |
| Total Debt | 1,664 | 930 | 10 | 33 |
InnoCan Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InnoCan Pharma Comparisons
Industry
Financing
Details
InnoCan Pharma Competitors (1)
One of InnoCan Pharma’s competitors is Formulex Pharma Innovations, a Corporation company based in Ness Ziona, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Formulex Pharma Innovations | Corporation | Ness Ziona, Israel |
InnoCan Pharma Patents
InnoCan Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4346801-A1 | Compositions for treatment of hair loss | Inactive | 28-Jul-2021 | ||
| EP-4346801-A4 | Compositions for treatment of hair loss | Inactive | 28-Jul-2021 | ||
| US-20240350518-A1 | Compositions for treatment of hair loss | Pending | 28-Jul-2021 | ||
| WO-2023007488-A1 | Compositions for treatment of hair loss | Inactive | 28-Jul-2021 | ||
| EP-4366728-A1 | Compositions for treatment of diabetic symptoms | Inactive | 08-Jul-2021 | A61K31/658 |
InnoCan Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
InnoCan Pharma Investments (2)
InnoCan Pharma’s most recent deal was a Joint Venture with Marketing & Online Sales of Skin & Body Care Products (Brandzon / Innocan). The deal was made on 16-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Marketing & Online Sales of Skin & Body Care Products (Brandzon / Innocan) | 16-Jun-2021 | Joint Venture | Specialty Retail | ||
| B.I. Sky Global | 06-Jun-2021 | Joint Venture | Consulting Services (B2B) |
InnoCan Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
InnoCan Pharma FAQs
-
When was InnoCan Pharma founded?
InnoCan Pharma was founded in 2018.
-
Where is InnoCan Pharma headquartered?
InnoCan Pharma is headquartered in Herzliya, Israel.
-
What is the size of InnoCan Pharma?
InnoCan Pharma has 11 total employees.
-
What industry is InnoCan Pharma in?
InnoCan Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is InnoCan Pharma a private or public company?
InnoCan Pharma is a Public company.
-
What is InnoCan Pharma’s stock symbol?
The ticker symbol for InnoCan Pharma is INNO.
-
What is the current stock price of InnoCan Pharma?
As of 13-Nov-2026 the stock price of InnoCan Pharma is $1.16.
-
What is the current market cap of InnoCan Pharma?
The current market capitalization of InnoCan Pharma is $5.2M.
-
What is InnoCan Pharma’s current revenue?
The trailing twelve month revenue for InnoCan Pharma is $23.5M.
-
Who are InnoCan Pharma’s competitors?
Formulex Pharma Innovations is a competitor of InnoCan Pharma.
-
What is InnoCan Pharma’s annual earnings per share (EPS)?
InnoCan Pharma’s EPS for 12 months was -$0.26.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
